Tenaya Therapeutics Inc (United States) is listed on the Nasdaq and has a market capitalization of $147.08 million, with shareholders equity totaling $69.41 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Tenaya Therapeutics Inc reported $1.33 million in revenue, generating net income of $-103.11 million.
Key financial metrics include a P/E ratio of -1.43, a price-to-book (P/B) ratio of 2.12, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker TNYA.